LL862-4
NBS_hear_risk
- Answer list
- LL862-4
- Answers
- 20
Answers
| Answer | Code | Score |
|---|---|---|
| Family Hx of hearing loss | LA12668-2 | |
| ICU stay > 5 days | LA12669-0 | |
| Hyperbilirubinemia with exchange transfusion | LA12673-2 | |
| Aminoglycoside administration for more than 5 days | LA12672-4 | |
| Asphyxia or Hypoxic Ischemic Encephalopathy | LA31563-2 | |
| ECMO | LA12670-8 | |
| In utero infection(s) such as herpes, rubella, syphilis, and toxoplasmosis | LA12674-0 | |
| In utero infection with cytomegalovirus (CMV) | LA31564-0 | |
| Mother + Zika and infant with no laboratory evidence and no clinical findings | LA31565-7 | |
| Mother + Zika and infant with laboratory evidence of Zika | LA31566-5 | |
| Craniofacial malformations: Other (e.g., ear dysplasia, oral facial clefting, white forelock, microphthalmia) | LA31852-9 | |
| Craniofacial malformations: microtia/atresia | LA31853-7 | |
| Congenital microcephaly, congenital or acquired hydrocephalus | LA31567-3 | |
| Temporal bone abnormalities | LA31568-1 | |
| Syndromes associated with atypical hearing thresholds | LA12676-5 | |
| Culture-positive infections associated with sensorineural hearing loss | LA12678-1 | |
| Significant head trauma | LA12679-9 | |
| Chemotherapy | LA6172-6 | |
| Caregiver concern about hearing | LA12667-4 | |
| None | LA137-2 |
Used by 1 tests
| LOINC |
|---|
| 58232-0 |